Medical specialists from Spain tagged as investigators in clinical trials studying Hepatitis

Total 50 results

Agustín Albillos Martínez
Seen in:
- Madrid, GSK Investigational Site
- Madrid, Hospital Universitario Ramón y Cajal
Trials:
- NCT04166773 (Principal Investigator)
- NCT05276297 (Principal Investigator)
- NCT05583344 (Principal Investigator)
Conditions:
Alvarez Giraldez Gallego, Dr.
Seen in:
- Sevilla, Hospital Universitario Virgen Del Rocio
Trials:
- NCT05070364 (Principal Investigator)
Conditions:
- Hepatitis Delta Virus
ANA BELEN PEREZ JIMENEZ
Seen in:
- Córdoba, Fundacion Investigacion Biomedica de Cordoba (Fibico)
Trials:
- NCT05062967 (Sub-Investigator)
Conditions:
ANA FUENTES LOPEZ
Seen in:
- Granada, Hospital Universitario San Cecilio
Trials:
- NCT05062967 (Principal Investigator)
Conditions:
Ana Guiberteau Sanchez
Seen in:
- Badajoz, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Andres Ruiz Sancho
Seen in:
- Granada, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
ANGELA CAMACHO ESPEJO
Seen in:
- Córdoba, Fundacion Investigacion Biomedica de Cordoba (Fibico)
Trials:
- NCT05062967 (Sub-Investigator)
Conditions:
ANTONIO AGUILERA GUIRAO
Seen in:
- Galicia, Santiago De Compostela, Fundacion Instituto de Investigacion Sanitaria de Santiago de Compostela
Trials:
- NCT05062967 (Principal Investigator)
Conditions:
Antonio Cuadrado Lavín, MDPhD
Seen in:
- Cantabria, Santander, Hospital Universitario Marqués de Valdecilla
Trials:
- NCT02745132 (Sub-Investigator)
Conditions:
- Hepatitis C
ANTONIO RIVERO ROMAN
Seen in:
- Córdoba, Fundacion Investigacion Biomedica de Cordoba (Fibico)
Trials:
- NCT05062967 (Principal Investigator)
Conditions:
CAROLINA FREYRE CARRILLO
Seen in:
- Cádiz, Puerto Real, Hospital de Puerto Real
Trials:
- NCT05062967 (Principal Investigator)
Conditions:
Conrado Fenandez Rodriguez
Seen in:
- Madrid, Alcorcon, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Cristina Masuet Aumatell
Seen in:
- Barcelona, GSK Investigational Site
- Hospitalet de Llobregat, GSK Investigational Site
Trials:
- NCT05590403 (Principal Investigator)
- NCT03866187 (Principal Investigator)
- NCT05921903 (Principal Investigator)
- NCT06374394 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections;
- Hepatitis B, Chronic
DAVID CANO TERRIZA
Seen in:
- Córdoba, Facultad de Veterinaria de Cordoba
Trials:
- NCT05062967 (Principal Investigator)
Conditions:
Francisco Gea Rodríguez
Seen in:
- Madrid, GSK Investigational Site
Trials:
- NCT03866187 (Principal Investigator)
Conditions:
- Hepatitis B, Chronic
GABRIEL REINA GONZALEZ
Seen in:
- Madrid, Clínica Universidad de Navarra
Trials:
- NCT05062967 (Principal Investigator)
Conditions:
Gemma Carrion Alonso
Seen in:
- Madrid, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Gloria Sanchez Antolin
Seen in:
- Valladolid, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Ignacio Perez Valero
Seen in:
- Córdoba, GSK Investigational Site
- Madrid, Hospital Universitatrio La Paz
Trials:
- NCT03696160 (Principal Investigator)
- NCT03866187 (Principal Investigator)
Conditions:
- HIV/AIDS;
- Hepatitis B, Chronic
Inmaculada Fernández Vázquez
Seen in:
- Madrid, GSK Investigational Site
Trials:
- NCT05630807 (Principal Investigator)
Conditions:
- Chronic Hepatitis B
ISABEL MARIA MACHUCA SANCHEZ
Seen in:
- Córdoba, Fundacion Investigacion Biomedica de Cordoba (Fibico)
Trials:
- NCT05062967 (Sub-Investigator)
Conditions:
ISABEL VICIANA RAMOS
Seen in:
- Málaga, Complejo Hospitalario de Especialidades Virgen de la Victoria
Trials:
- NCT05062967 (Principal Investigator)
Conditions:
Javier Ampuero Herrojo
Seen in:
- Sevilla, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
Conditions:
Javier Crespo
Seen in:
- Santander, GSK Investigational Site
Trials:
- NCT05583344 (Principal Investigator)
- NCT03866187 (Principal Investigator)
Conditions:
- Nonalcoholic Fatty Liver Disease;
- Hepatitis B, Chronic
Javier Garcia Samaniego
Seen in:
- Madrid, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT05276297 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Javier Garcia Samaniego Rey, Dr.
Seen in:
- Madrid, Hospital Universitario La Paz
Trials:
- NCT03719313 (Principal Investigator)
Conditions:
- Hepatitis Delta Virus
Joaquín Cabeza González
Seen in:
- Santander, GSK Investigational Site
Trials:
- NCT04954859 (Principal Investigator)
Conditions:
- Hepatitis B
Joaquín Cabezas González
Seen in:
- Santander, GSK Investigational Site
Trials:
- NCT05276297 (Principal Investigator)
Conditions:
- Hepatitis B, Chronic
JOSE FRANCISCO RUIZ FONS
Seen in:
- Ciudad Real, Instituto de Investigacion En Recursos Cinegeticos (Irec)
Trials:
- NCT05062967 (Principal Investigator)
Conditions:
José Hernandez-Quero
Seen in:
- Granada, GSK Investigational Site
Trials:
- NCT03866187 (Principal Investigator)
Conditions:
- Hepatitis B, Chronic

Clinical Trials on Hepatitis

National Taiwan University Hospital
National Science Council, Taiwan; National Health Research Institutes, Taiwan

Unknown

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta

Chronic Hepatitis B | Chronic Hepatitis D

Taiwan
University of Maryland, Baltimore
Alexandria University; MADAUS GmbH; The Egyptian Company for Blood Transfusion... and other collaborators

Terminated

Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis

Acute Hepatitis C | Acute Hepatitis B | Acute Hepatitis A | Acute Hepatitis E | Acute EBV Hepatitis | Acute CMV Hepatitis

Egypt
Gilead Sciences

Completed

Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Chronic Hepatitis Delta

France, Moldova, Republic of, Romania, Russian Federation
Ziauddin Hospital

Unknown

Ezetimibe for Patients With Chronic Hepatitis D

Chronic Hepatitis D

Pakistan
Hepatera Ltd.

Completed

Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection

Chronic Hepatitis D Infection
AbbVie

Completed

Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

Chronic Hepatitis C | Hepatitis C (HCV) | Hepatitis C Genotype 1a
AbbVie (prior sponsor, Abbott)

Completed

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Chronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV)

United States, Australia, Canada, France, Germany, New Zealand, Puerto Rico, Spain, United Kingdom
PharmaEssentia

Recruiting

The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection

Chronic Hepatitis B Infection | Chronic Hepatitis D Infection

Taiwan
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection (CERTAIN-2)

Hepatitis C Virus | Chronic Hepatitis C Virus
AbbVie (prior sponsor, Abbott)

Completed

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

Hepatitis C | Chronic Hepatitis C Infection | HCV | Hepatitis C Genotype 1

United States

Medical specialists from Spain tagged as investigators in clinical trials studying Hepatitis

Clinical Trials on Hepatitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations